These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Relationship between aberrant FHIT transcripts and hepatocellular carcinoma]. Yu YC; Sun FY; Li Z; Lu SY; Teng XH Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):550-1. PubMed ID: 14552718 [TBL] [Abstract][Full Text] [Related]
3. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis. Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760 [TBL] [Abstract][Full Text] [Related]
4. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma. Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452 [TBL] [Abstract][Full Text] [Related]
5. Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract. Chen YJ; Chen PH; Lee MD; Chang JG Int J Cancer; 1997 Sep; 72(6):955-8. PubMed ID: 9378557 [TBL] [Abstract][Full Text] [Related]
6. Alterations of the FHIT gene in human hepatocellular carcinoma. Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123 [TBL] [Abstract][Full Text] [Related]
7. Analysis of FHIT transcripts in cervical and endometrial cancers. Su TH; Wang JC; Tseng HH; Chang CP; Chang TA; Wei HJ; Chang JG Int J Cancer; 1998 Apr; 76(2):216-22. PubMed ID: 9537583 [TBL] [Abstract][Full Text] [Related]
8. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130 [TBL] [Abstract][Full Text] [Related]
9. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782 [TBL] [Abstract][Full Text] [Related]
10. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423 [TBL] [Abstract][Full Text] [Related]
11. Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea. Nam CW; Shin JW; Park NH World J Gastroenterol; 2008 Jun; 14(22):3526-33. PubMed ID: 18567082 [TBL] [Abstract][Full Text] [Related]
12. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880 [TBL] [Abstract][Full Text] [Related]
13. FHIT mRNA and protein expression in hepatocellular carcinoma. Kannangai R; Sahin F; Adegbola O; Ashfaq R; Su GH; Torbenson M Mod Pathol; 2004 Jun; 17(6):653-9. PubMed ID: 15060557 [TBL] [Abstract][Full Text] [Related]
14. Expression of aberrant functional and nonfunctional transcripts of the FHIT gene in Burkitt's lymphomas. Ferrer M; López-Borges S; Lazo PA Mol Carcinog; 1999 May; 25(1):55-63. PubMed ID: 10331745 [TBL] [Abstract][Full Text] [Related]
15. Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites. Manning AP; Mes-Masson AM; Seymour RJ; Tetrault M; Provencher DM; Tonin PN Mol Carcinog; 1999 Mar; 24(3):218-25. PubMed ID: 10204806 [TBL] [Abstract][Full Text] [Related]
16. HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA. Chu TY; Shen CY; Chiou YS; Lu JJ; Perng CL; Yu MS; Liu HS Int J Cancer; 1998 Jan; 75(2):199-204. PubMed ID: 9462708 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the FHIT gene in human prostate cancer. Latil A; Bièche I; Fournier G; Cussenot O; Pesche S; Lidereau R Oncogene; 1998 Apr; 16(14):1863-8. PubMed ID: 9583683 [TBL] [Abstract][Full Text] [Related]
18. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Hendricks DT; Taylor R; Reed M; Birrer MJ Cancer Res; 1997 Jun; 57(11):2112-5. PubMed ID: 9187105 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768 [TBL] [Abstract][Full Text] [Related]
20. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma. Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]